Advertisement

Topics

Endocrine Technologies Incorporated Company Profile

16:38 EST 18th November 2017 | BioPortfolio

endocrinetechnologies Incorporated USA is a biodiagnostic company specializing in in vitro diagnostics for human application and veterinary application. The company dveleops, manufactures a variety of immuno assay test kits for R&D use for various species. The company also provide a variety of services in the area of formulation, biochemical and immunochemical analysis. The company has been established since 1994 and is held privately.

Location

35325 Fircrest Street
Newark
CA
94560-1003
United States of America

Contact

Phone: 510 745 0844
Fax: 510 745 0977


News Articles [365 Associated News Articles listed on BioPortfolio]

'Omics' and endocrine-disrupting chemicals — new paths forward

The emerging field of omics has the potential to advance and strengthen research into endocrine-disrupting chemicals (EDCs). In this Opinion article, Andrea Baccarelli and colleagues discuss the poten...

Endocrine Society issues Scientific Statement on obesity's causes

(The Endocrine Society) A new Scientific Statement issued by the Endocrine Society calls for more research aimed specifically at understanding the underlying mechanisms that make it difficult to maint...

Endocrine Society statement addresses obesity mechanisms

The Endocrine Society is calling on researchers to address the underlying mechanisms that make it difficult to maintain long-term weight loss in obesity, according to a scientific statement published ...

Endocrine Society announces 2018 Laureate Award winners

(The Endocrine Society) The Endocrine Society today announced it has selected 14 leaders in the endocrinology field as winners of its prestigious 2018 Laureate Awards.

Endocrine Society announces Early Investigators Award winners

(The Endocrine Society) The Endocrine Society has selected 22 new recipients for its Early Investigators Awards.

ESMO 2017: Abemaciclib initial therapy improves outcome in endocrine-sensitive advanced breast cancer

The results of the MONARCH 3 trial, presented at the ESMO 2017 Congress in Madrid, showed that adding the cyclin-dependent kinase (CDK) 4/6 inhibitor abemaciclib to endocrine therapy improved progress...

Statistical Approaches for Estimating Sex-Specific Effects in Endocrine Disruptors Research

Introduction Research on health effects of endocrine-disrupting chemicals (EDs) has increased rapidly in the last decade. This work is predicated on the principle that chemicals that interact with the...

Application of Adverse Outcome Pathways to U.S. EPA’s Endocrine Disruptor Screening Program

Introduction Many chemicals have the potential to interfere with normal endocrine functioning, which may lead to a variety of adverse outcomes including developmental deformities, impaired reproductio...

PubMed Articles [775 Associated PubMed Articles listed on BioPortfolio]

Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline.

To update the "Endocrine Treatment of Transsexual Persons: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2009.

New agents for endocrine resistance in breast cancer.

Estrogen receptor positive (ER+) and HER2-negative (HER2-) breast cancer (BC) is the most common BC subtype, defined by expression of the ER and absence of HER2 amplification. Endocrine treatment (ET)...

Health technology assessments conducted in health care facilities: A strategic practice? Findings from a content analysis of HTA reports.

In this paper, we test the hypothesis that health technology assessment units located in hospitals tend to be more optimistic toward technologies that are currently in use in their organization than t...

Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer: A network meta-analysis.

Endocrine therapy was recommended as the preferred first-line treatment for hormone receptor-positive (HR+, i.e., ER+ and/or PgR+), human epidermal growth factor receptor-2-negative (HER2-) postmenopa...

Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.

The European Society of Endocrinology and the Pediatric Endocrine Society. This guideline was funded by the Endocrine Society.

Clinical Trials [705 Associated Clinical Trials listed on BioPortfolio]

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

This trial studies the effects on quality of life and on time to second progression of the sequence endocrine therapy-capecitabine versus the sequence capecitabine-endocrine treatment. It ...

Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy

The purpose of this study is to evaluate radiotherapy followed by endocrine therapy in comparison with endocrine therapy alone for PSA failure after radical prostatectomy.

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination with a drug called Palbociclib or Endocrine treatment al...

Evaluation of Patients With Endocrine-Related Conditions

This study will evaluate patients with a variety of endocrine disorders in order to 1) learn more about conditions that affect the endocrine glands (glands that secrete hormones) and 2) to...

An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms

A single institutional study of Pancreatic Endocrine Neoplasms over 18 years.

Companies [1300 Associated Companies listed on BioPortfolio]

Endocrine Technologies

Welcome to Endocrine Technologies Located in the San Francisco Bay Area, Endocrine Technologies is dedicated to research, development, manufacture and distribution of innovative new scientific discove...

Neurocrine Biosciences

Neurocrine Biosciences is a leading neuroscience company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases...

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in t...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

Endocrine Technology, L.L.C.

More Information about "Endocrine Technologies Incorporated" on BioPortfolio

We have published hundreds of Endocrine Technologies Incorporated news stories on BioPortfolio along with dozens of Endocrine Technologies Incorporated Clinical Trials and PubMed Articles about Endocrine Technologies Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endocrine Technologies Incorporated Companies in our database. You can also find out about relevant Endocrine Technologies Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...


Corporate Database Quicklinks



Searches Linking to this Company Record